UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exploration of machine learning techniques in predicting multiple sclerosis disease course

PloS one, 2017-04, Vol.12 (4), p.e0174866-e0174866

2017

Volltextzugriff (PDF)

Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts

Brain pathology (Zurich, Switzerland), 2018-11, Vol.28 (6), p.791-805

2018

Volltextzugriff (PDF)

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

The Lancet (British edition), 2012-11, Vol.380 (9856), p.1829-1839

2012

Volltextzugriff (PDF)

Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012

Pediatric neurology, 2013-12, Vol.49 (6), p.439-444

2013

Volltextzugriff (PDF)

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis

Annals of neurology, 2013-06, Vol.73 (6), p.729-740

2013

Volltextzugriff (PDF)

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

The Lancet (British edition), 2012-11, Vol.380 (9856), p.1819-1828

2012

Volltextzugriff (PDF)

IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production

The Journal of immunology (1950), 2006-06, Vol.176 (12), p.7768-7774

2006

Volltextzugriff (PDF)

Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE

Nature immunology, 2009-09, Vol.10 (9), p.958-964

2009

Volltextzugriff (PDF)

Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis

Brain (London, England : 1878), 2017-07, Vol.140 (7), p.1900-1913

2017

Volltextzugriff (PDF)

Multiple sclerosis in Hispanics: a study of clinical disease expression

Multiple sclerosis, 2011-08, Vol.17 (8), p.1010-1016

2011

Volltextzugriff (PDF)

Severity of manifestations in tuberous sclerosis complex in relation to genotype

Epilepsia (Copenhagen), 2014-07, Vol.55 (7), p.1025-1029

2014

Volltextzugriff (PDF)

Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome

Nature communications, 2021-12, Vol.12 (1), p.7078-7078, Article 7078

2021

Volltextzugriff (PDF)

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells

Neurology, 2009-06, Vol.72 (22), p.1922-1930

2009

Volltextzugriff (PDF)

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

The Journal of experimental medicine, 2004-04, Vol.199 (7), p.971-979

2004

Volltextzugriff (PDF)

Work Productivity in Relapsing Multiple Sclerosis: Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life

Value in health, 2012-12, Vol.15 (8), p.1029-1035

2012

Volltextzugriff (PDF)

Demographic and clinical characteristics of malignant multiple sclerosis

Neurology, 2011-06, Vol.76 (23), p.1996-2001

2011

Volltextzugriff (PDF)

Meta-analysis identifies common gut microbiota associated with multiple sclerosis

Genome medicine, 2024-07, Vol.16 (1), p.94-13, Article 94

2024

Volltextzugriff (PDF)

Antigen microarrays identify CNS-produced autoantibodies in RRMS

Neurology, 2012-02, Vol.78 (8), p.532-539

2012

Volltextzugriff (PDF)

Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk

Annals of neurology, 2016-02, Vol.79 (2), p.178-189

2016

Volltextzugriff (PDF)

Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis

Frontiers in immunology, 2024-04, Vol.15, p.1360219

2024

Volltextzugriff (PDF)

Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort

JAMA neurology, 2015-02, Vol.72 (2), p.152

2015

Volltextzugriff (PDF)

Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study

Journal of neuroimaging, 2020-03, Vol.30 (2), p.212-218

2020

Volltextzugriff (PDF)

Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease

The Journal of clinical investigation, 2003-08, Vol.112 (3), p.415-422

2003

Volltextzugriff (PDF)

Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study

Frontiers in immunology, 2021-08, Vol.12, p.709861-709861

2021

Volltextzugriff (PDF)

A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

Annals of neurology, 2015-07, Vol.78 (1), p.115-127

2015

Volltextzugriff (PDF)

1 – 25 von 1.006

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(920)
Mit Volltextzugriff
(733)

Publikationsform

Artikel
(1.005)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neurology
(44)
The New England Journal Of Medicine
(20)
Obstetrics And Gynecology
(16)
Journal Of Neuroimmunology
(15)
Archives Of Neurology
(14)
Journal Of Clinical Oncology
(14)
Multiple Sclerosis
(13)
American Journal Of Obstetrics And Gynecology
(12)
Neurosurgery
(11)
Plos One
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Exploration of machine learning techniques in predicting multiple sclerosis disease course

Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production

Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE

Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis

Multiple sclerosis in Hispanics: a study of clinical disease expression

Severity of manifestations in tuberous sclerosis complex in relation to genotype

Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

Work Productivity in Relapsing Multiple Sclerosis: Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life

Demographic and clinical characteristics of malignant multiple sclerosis

Meta-analysis identifies common gut microbiota associated with multiple sclerosis

Antigen microarrays identify CNS-produced autoantibodies in RRMS

Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk

Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis

Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort

Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study

Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease

Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study

A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

Aktive Filter

Suchergebnisse filtern